drugset / Trial / NCT03518242
Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
This phase I trial studies the molecular profile of breast cancer in Ugandan patients with stage IIB-III breast cancer. Creating a molecular profile of breast cancer my help doctors learn more about biological factors associated with breast cancer in Ugandan patients with as well as measure the benefits of locally available diagnostic studies and the possibility of providing treatment via oral medication.
Timeline
- Start
- 2018-06-06
- Primary completion
- 2022-05-04
- Completion
- 2022-05-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | — | Oral |
| Subject | Cyclophosphamide | Other / unclassified | — | Oral |
| Subject | Methotrexate | Small molecule | — | Oral |